Company
iEcure
iECURE is a clinical-stage biotechnology company developing genome editing therapies for rare, life-threatening genetic diseases.
Also known as iECURE Inc
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- United States
- Legal name
- iECURE Inc
Claim, correct or request removal
Record updated 28 September 2026
About
At iECURE, we are advancing innovative genetic therapies designed to address the underlying cause of neurometabolic disorders, with the goal of delivering lasting benefit for patients and families.
Products
- Other
- ECUR-506
Loading relationship preview